This page uses content from Wikipedia and is licensed under CC BY-SA.

Darodipine

Darodipine
Darodipine structure.svg
Names
IUPAC name
4-(2,1,3-Benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
Properties
C19H21N3O5
Molar mass 371.393 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Darodipine is an experimental calcium channel blocker that based on animal models may reduce neuronal cytoskeletal alterations during aging and in neurodegenerative disorders.<ref>Amenta, Francesco; Ferrante, Fabio; Mancini, Maurizio; Sabbatini, Maurizio; Vega, Joséantonio; Zaccheo, Damiano (1995). "Effect of long term treatment with the dihydropyridine-type calcium channel blocker darodipine (PY 108-068) on the cerebral capillary network in aged rats". Mechanisms of Ageing and Development. 78: 27–37. doi:10.1016/0047-6374(94)01513-L.

See also

References